Bioinformatyka w poszukiwaniu nowych leków

• Authors: Krzysztof Pawłowski

Title variants

EN

Bioinformatics in search of novel drugs

• Languages of publication: PL EN

Abstracts

EN

In the process of novel drugs creation, today's pharmaceutical industry applies a whole spectrum of advanced research methods for elucidation of disease mechanisms, finding and selection of the right points of therapeutic intervention, designing a proper means of intervention (drug candidate), evaluation of safety and efficacy of the candidate and evaluation of the drug in clinical trials. At each stage of this complicated process, the computational techniques of biology, herein collectively called "bioinformatics", are an indispensable element of the research toolkit. In this article, are discussed the most common applications of bioinformatics, and challenges posed by the development of biology and medicine, as well as the evolving model of the drug discovery process

• Journal: Kosmos
• Year: 2009
• Volume: 58
• Issue: 1-2
• Pages: 127-134

Dates

published

2009

Contributors

author

Krzysztof Pawłowski

• Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Pasteura 3, 02-093 Warszawa, Polska

References

• Bujnicki J. M., 2005. Przewidywanie struktury białek: podejście boltzmannowskie i darwinowskie Kosmos 54, 155-162.
• Cavasotto C. N., Phatak S. S. 2009. Homology modeling in drug discovery: current trends and applications. Drug Discov Today.
• Couzin-Frankel J., 2009. Genetics. The promise of a cure: 20 years and counting. Science 324, 1504-1507.
• Dowsett M., Dunbier A. K., 2008. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin. Cancer Res. 14, 8019-8026.
• Ekins S., Nikolsky Y., Bugrim A., Kirillov E., Nikolskaya T., 2007. Pathway mapping tools for analysis of high content data. Methods Mol. Biol. 356, 319-350.
• Gresham V., McLeod H. L., 2009. Genomics: applications in mechanism elucidation. Adv. Drug Deliv. Rev. 61, 369-374.
• Hackett N. R., Heguy A., Harvey B. G., O'connor T. P., Luettich K., Flieder D. B., Kaplan R., Crystal R., G., 2003. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am. J. Respir. Cell. Mol. Biol. 29, 331-343.
• Heist R. S., Christiani D., 2009. EGFR-targeted therapies in lung cancer: predictors of response and toxicity. Pharmacogenomics 10, 59-68.
• Hoffmann R., Valencia A., 2003. Life cycles of successful genes. Trends Genet. 19, 79-81.
• Holbrook J. D., Sanseau P., 2007. Drug discovery and computational evolutionary analysis. Drug Discov. Today. 12, 826-832.
• Jenwitheesuk E., Horst J. A., Rivas K. L., Van Voorhis W. C., Samudrala R., 2008. Novel paradigms for drug discovery: computational multitarget screening. Trends Pharmacol. Sci. 29, 62-71.
• Jones S., Zhang X., Parsons D. W., Lin J. C., Leary R. J., Angenendt P. i współaut., 2008. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 321, 1801-1806.
• Mai V., Draganov P. V., 2009. Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J., Gastroenterol. 15, 81-85.
• O'Keefe S., J. 2008. Nutrition and colonic health: the critical role of the microbiota. Curr. Opin. Gastroenterol. 24, 51-58.
• Osborne J. D., Zhu L. J., Lin S. M., Kibbe W. A., 2007. Interpreting microarray results with gene ontology and MeSH. Methods Mol. Biol. 377, 223-242.
• Pawłowski K., 2008. Uncharacterized/hypothetical proteins in biomedical 'omics' experiments: is novelty being swept under the carpet? Brief Funct. Genomic Proteomic 7, 283-290.
• Pawłowski K., Lepisto M., Meinander N., Sivars U., Varga M., Wieslander E., 2006. Novel conserved hydrolase domain in the CLCA family of alleged calcium-activated chloride channels. Proteins 63, 424-439.
• Pennisi E., 2008. Personal genomics. Number of sequenced human genomes doubles. Science 322, 838.
• Plewczyński D., Rychlewski L. 2009. Meta-basic estimates the size of druggable human genome. J Mol Model. 15, 695-699
• Proell M., Riedl S. J., Fritz J. H., Rojas A. M., Schwarzenbacher R., 2008. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One 3, e2119.
• Sams-Dodd F., 2006. Drug discovery: selecting the optimal approach. Drug Discov. Today 11, 465-472.
• Shekhar C., 2008. In silico pharmacology: computer-aided methods could transform drug development. Chem. Biol. 15, 413-414.
• Smith P. J., Khan I. A., Errington R. J., 2009. Cytomics and cellular informatics--coping with asymmetry and heterogeneity in biological systems. . Drug Discov. Today 14, 271-277.
• Wiley H. S., Shvartsman S. Y., Lauffenburger D. A., 2003. Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell. Biol. 13, 43-50.